Scarica l'app Stockscreener
35.87
1.68%
-0.64
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$36.51
Aprire:
$36.51
Volume 24 ore:
673.02K
Relative Volume:
0.17
Capitalizzazione di mercato:
$15.11B
Reddito:
$2.26B
Utile/perdita netta:
$1.09B
Rapporto P/E:
15.31
EPS:
2.3431
Flusso di cassa netto:
$2.70B
1 W Prestazione:
+0.07%
1M Prestazione:
+2.27%
6M Prestazione:
+15.98%
1 anno Prestazione:
+29.63%
Intervallo 1D:
$35.80
$36.89
Intervallo di 1 settimana:
$35.51
$36.89
Portata 52W:
$24.05
$36.89
Royalty Pharma Plc Stock (RPRX) Company Profile
Nome
Royalty Pharma Plc
Settore
Industria
Telefono
(212) 883-0200
Indirizzo
110 EAST 59TH STREET, NEW YORK, NY
Confronta RPRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RPRX
Royalty Pharma Plc
|
35.86 | 14.96B | 2.26B | 1.09B | 2.70B | 2.3431 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.22 | 119.76B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.06 | 59.14B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
315.64 | 41.40B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
568.13 | 32.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
278.34 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-16 | Iniziato | Morgan Stanley | Overweight |
| 2024-06-03 | Downgrade | UBS | Buy → Neutral |
| 2022-06-14 | Ripresa | UBS | Buy |
| 2022-05-13 | Iniziato | Scotiabank | Sector Outperform |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2022-04-14 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-04-06 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-29 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-07-30 | Iniziato | Tigress Financial | Buy |
| 2020-11-09 | Aggiornamento | UBS | Neutral → Buy |
| 2020-07-14 | Iniziato | Evercore ISI | In-line |
| 2020-07-13 | Iniziato | BofA Securities | Buy |
| 2020-07-13 | Iniziato | Citigroup | Neutral |
| 2020-07-13 | Iniziato | Cowen | Outperform |
| 2020-07-13 | Iniziato | Goldman | Neutral |
| 2020-07-13 | Iniziato | JP Morgan | Neutral |
| 2020-07-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-07-13 | Iniziato | SunTrust | Buy |
| 2020-07-13 | Iniziato | UBS | Neutral |
Mostra tutto
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Royalty Pharma (NASDAQ:RPRX) Hits New 12-Month HighStill a Buy? - MarketBeat
Why Royalty Pharma plc stock attracts strong analyst attentionDaily Swing Candidates - Newser
How Royalty Pharma plc stock performs during market volatilityMarket Timing Advice - beatles.ru
What makes Royalty Pharma plc stock price move sharplyFree Trading Group - Newser
M&T Bank Corp Increases Stock Position in Royalty Pharma PLC (NASDAQ:RPRX) - Defense World
Strata Wealth Advisors LLC Purchases Shares of 12,430 Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Bank of New York Mellon Corp Has $45.53 Million Stake in Royalty Pharma PLC (NASDAQ:RPRX) - Defense World
D.A. Davidson & CO. Trims Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Rehmann Capital Advisory Group Purchases New Position in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma stock hits 52-week high at 36.44 USD By Investing.com - Investing.com South Africa
Royalty Pharma PLC (NASDAQ:RPRX) Stake Lessened by China Universal Asset Management Co. Ltd. - MarketBeat
Royalty Pharma stock hits 52-week high at 36.44 USD - Investing.com
Royalty Pharma PLC (NASDAQ:RPRX) Stock Holdings Boosted by Amalgamated Bank - Defense World
Royalty Pharma PLC (NASDAQ:RPRX) Shares Sold by Vontobel Holding Ltd. - Defense World
Sumitomo Mitsui DS Asset Management Company Ltd Acquires 13,615 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
(RPRX) Trading Report - news.stocktradersdaily.com
Benign Growth For Royalty Pharma plc (NASDAQ:RPRX) Underpins Its Share Price - simplywall.st
Wealth Enhancement Advisory Services LLC Has $509,000 Position in Royalty Pharma PLC (NASDAQ:RPRX) - Defense World
Royalty Pharma PLC (NASDAQ:RPRX) Shares Acquired by Mirae Asset Global Investments Co. Ltd. - MarketBeat
New South Capital Management Inc. Sells 49,656 Shares of Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week HighShould You Buy? - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Downgraded by Wall Street Zen to Hold - MarketBeat
Royalty Pharma stock hits 52-week high at $36.32 By Investing.com - Investing.com Nigeria
Royalty Pharma stock hits 52-week high at $36.32 - Investing.com
Royalty Pharma plc(NasdaqGS: RPRX) dropped from Russell 1000 Defensive Index - MarketScreener
Royalty Pharma PLC (NASDAQ:RPRX) Shares Sold by Paragon Capital Management Inc. - MarketBeat
Investors in Royalty Pharma (NASDAQ:RPRX) have seen respectable returns of 40% over the past year - Yahoo
Robeco Institutional Asset Management B.V. Grows Stock Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
(RPRX) Investment Report - news.stocktradersdaily.com
Royalty Pharma PLC (NASDAQ:RPRX) Shares Sold by Manning & Napier Advisors LLC - MarketBeat
Is Royalty Pharma Plc technically bullish or bearish? - MarketsMojo
Royalty Pharma Announces $2 Billion Funding Arrangement with Revolution Medicines for Daraxonrasib Development - Nasdaq
Revolution Medicines To Advance Lead Cancer Drug With $2 Billion In Funds - Benzinga
Royalty Pharma stock hits 52-week high at $35.41 By Investing.com - Investing.com India
Advisor Resource Council Makes New Investment in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Yousif Capital Management LLC Purchases New Holdings in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
SG Americas Securities LLC Invests $1.67 Million in Royalty Pharma PLC (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) On An Uptrend: Could Fundamentals Be Driving The Stock? - simplywall.st
Royalty Pharma PLC (NASDAQ:RPRX) Shares Sold by Bank Pictet & Cie Europe AG - MarketBeat
Wealth Enhancement Advisory Services LLC Takes Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Wealth Enhancement Advisory Services LLC Acquires New Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
(RPRX) Trading Signals - news.stocktradersdaily.com
Short Interest in Royalty Pharma plc (NASDAQ:RPRX) Expands By 39.9% - MarketBeat
53,487 Shares in Royalty Pharma plc (NASDAQ:RPRX) Bought by SG Americas Securities LLC - Defense World
Merit Financial Group LLC Makes New $252,000 Investment in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
GAMMA Investing LLC Increases Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Reaches New 12-Month HighWhat's Next? - MarketBeat
Pallas Capital Advisors LLC Has $3.13 Million Position in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma stock hits 52-week high at $34.33 amid robust growth - Investing.com
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Handelsbanken Fonder AB - MarketBeat
Wedge Capital Management L L P NC Buys Shares of 1,014,799 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma Plc Azioni (RPRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):